Aerodose Insulin Inhaler Clinical Trials

Objective

Location

Reported

Study

Phase 1

Inhaled insulin vs. subcutaneous injection

Manchester, UK

Fishman et al, Diabetes 2000, 49 (suppl. 1):A 121

ADA, June 2001

Phase 2a

Intrapatient variability

Dose proportionality

San Diego, Calif. USA

EASD, Sept. 2001

Study completed

ADA, June 2002

Inhaled aerosol particle size and flow

Neuss, Germany

Phase 1